02650nam 2200589Ia 450 991078339190332120200520144314.01-280-08856-797866100885601-4175-4657-392-4-068071-3(CKB)1000000000024444(EBL)284674(OCoLC)437176298(SSID)ssj0000177348(PQKBManifestationID)11182248(PQKBTitleCode)TC0000177348(PQKBWorkID)10210833(PQKB)11667697(MiAaPQ)EBC284674(Au-PeEL)EBL284674(CaPaEBR)ebr10067182(CaONFJC)MIL8856(NjHacI)991000000000024444(EXLCZ)99100000000002444420040714d2004 uy 0engur|n|---|||||txtccrImproving access and use of psychotropic medicines[electronic resource] mental health policy and service guidance packageGeneva World Health Organization2004Geneva :World Health Organization,2004.1 online resource (74 p.)Description based upon print version of record.92-4-154641-7 Includes bibliographical references.Preliminaries; Contents; Preface; Executive summary; 1. Introduction; 2. Improving access to psychotropics; 3. Promoting appropriate use of psychotropics; 4. Assessing a psychotropic access system; 5. A seven-step approach to improving access to psychotropics; Annex 1. Examples of treatment for disorders, including their pharmacological effectiveness; ReferencesThis module provides practical guidance on how to improve access to psychotropic drugs and promote their effective use. Issues such as the rational selection of drugs, affordability, sustainable financing and the availability of reliable health and supply systems are discussed in order to demonstrate practical ways to promote access. A number of educational, managerial and regulatory strategies to promote the effective use of psychotropic medicines are also highlighted.Psychotropic drugsSupply and demandMental illnessChemotherapyPsychotropic drugsSupply and demand.Mental illnessChemotherapy.616.8527061MiAaPQMiAaPQMiAaPQBOOK9910783391903321Improving access and use of psychotropic medicines3672699UNINA